---
layout: default
title: Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble
---

# Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble

**arXiv**: [2512.14648v1](https://arxiv.org/abs/2512.14648) | [PDF](https://arxiv.org/pdf/2512.14648.pdf)

**ä½œè€…**: Daniel CapellÃ¡n-MartÃ­n, Abhijeet Parida, Zhifan Jiang, Nishad Kulkarni, Krithika Iyer, Austin Tapp, Syed Muhammad Anwar, MarÃ­a J. Ledesma-Carbayo, Marius George Linguraru

**åˆ†ç±»**: cs.CV, eess.IV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

**å¤‡æ³¨**: 12 pages, 5 figures, 3 tables. Algorithm presented at MICCAI BraTS 2025

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¯é€‚åº”è„‘è‚¿ç˜¤åˆ†å‰²æµç¨‹ï¼Œé€šè¿‡å½±åƒç»„å­¦å¼•å¯¼äºšåž‹è¯†åˆ«å’Œç—…ç¶çº§æ¨¡åž‹é›†æˆæå‡å¤šç±»åž‹è‚¿ç˜¤åˆ†å‰²æ€§èƒ½ã€‚**

**å…³é”®è¯**: `è„‘è‚¿ç˜¤åˆ†å‰²` `å¤šå‚æ•°MRI` `å½±åƒç»„å­¦` `æ¨¡åž‹é›†æˆ` `ç—…ç¶çº§å¤„ç†` `è‡ªé€‚åº”æµç¨‹` `ä¸´åºŠå½±åƒåˆ†æž` `BraTSæŒ‘æˆ˜èµ›`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ ¸å¿ƒé—®é¢˜ï¼šè„‘è‚¿ç˜¤ç±»åž‹å¤šæ ·ï¼ŒçŽ°æœ‰åˆ†å‰²æ–¹æ³•éš¾ä»¥åœ¨MRIä¸Šå®žçŽ°ç¨³å¥ä¸”å¯æ³›åŒ–çš„åˆ†å‰²ï¼Œå°¤å…¶æ˜¯åœ¨æˆäººåŠå„¿ç«¥è‚¿ç˜¤ã€è„‘è†œç˜¤å’Œè½¬ç§»ç˜¤ç­‰ä¸åŒæ•°æ®é›†ä¸Šã€‚
2. æ–¹æ³•è¦ç‚¹ï¼šæå‡ºçµæ´»å¯é€‚åº”æµç¨‹ï¼Œç»“åˆå½±åƒç»„å­¦å¼•å¯¼äºšåž‹è¯†åˆ«ã€ç—…ç¶çº§æ¨¡åž‹é›†æˆå’Œå®šåˆ¶åŽå¤„ç†ï¼Œé’ˆå¯¹ä¸åŒè‚¿ç˜¤ç±»åž‹ä¼˜åŒ–åˆ†å‰²æ­¥éª¤ã€‚
3. å®žéªŒæˆ–æ•ˆæžœï¼šåœ¨BraTS 2025 LighthouseæŒ‘æˆ˜èµ›çš„å¤šä¸ªæµ‹è¯•é›†ä¸Šï¼Œæ€§èƒ½ä¸Žé¡¶çº§ç®—æ³•ç›¸å½“ï¼Œè¯å®žäº†æ–¹æ³•çš„æœ‰æ•ˆæ€§å’Œæ³›åŒ–èƒ½åŠ›ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨å¤šå‚æ•°ç£å…±æŒ¯æˆåƒï¼ˆMRIï¼‰ä¸Šå®žçŽ°ç¨³å¥ä¸”å¯æ³›åŒ–çš„è„‘è‚¿ç˜¤åˆ†å‰²ä»ç„¶å›°éš¾ï¼Œå› ä¸ºè‚¿ç˜¤ç±»åž‹å·®å¼‚å¾ˆå¤§ã€‚BraTS 2025 LighthouseæŒ‘æˆ˜èµ›åœ¨å¤šæ ·åŒ–çš„é«˜è´¨é‡æˆäººåŠå„¿ç«¥è‚¿ç˜¤æ•°æ®é›†ä¸Šè¯„ä¼°åˆ†å‰²æ–¹æ³•ï¼šå›½é™…å¤šä¸­å¿ƒå„¿ç«¥è„‘è‚¿ç˜¤åˆ†å‰²ï¼ˆPEDï¼‰ã€æœ¯å‰è„‘è†œç˜¤åˆ†å‰²ï¼ˆMENï¼‰ã€è„‘è†œç˜¤æ”¾ç–—åˆ†å‰²ï¼ˆMEN-RTï¼‰ä»¥åŠæ²»ç–—å‰åŽè„‘è½¬ç§»ç˜¤åˆ†å‰²ï¼ˆMETï¼‰ã€‚æˆ‘ä»¬æå‡ºäº†ä¸€ç§çµæ´»ã€æ¨¡å—åŒ–ä¸”å¯é€‚åº”çš„æµç¨‹ï¼Œé€šè¿‡é€‰æ‹©å’Œç»„åˆæœ€å…ˆè¿›çš„æ¨¡åž‹ï¼Œå¹¶åœ¨è®­ç»ƒå‰åŽåº”ç”¨è‚¿ç˜¤å’Œç—…ç¶ç‰¹å¼‚æ€§å¤„ç†æ¥æå‡åˆ†å‰²æ€§èƒ½ã€‚ä»ŽMRIä¸­æå–çš„å½±åƒç»„å­¦ç‰¹å¾æœ‰åŠ©äºŽæ£€æµ‹è‚¿ç˜¤äºšåž‹ï¼Œç¡®ä¿æ›´å¹³è¡¡çš„è®­ç»ƒã€‚å®šåˆ¶çš„ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡ç¡®å®šé›†æˆä¸­æ¯ä¸ªæ¨¡åž‹çš„å½±å“ï¼Œå¹¶ä¼˜åŒ–è¿›ä¸€æ­¥ç»†åŒ–é¢„æµ‹çš„åŽå¤„ç†ï¼Œä½¿å·¥ä½œæµç¨‹èƒ½å¤Ÿé’ˆå¯¹æ¯ä¸ªç—…ä¾‹å®šåˆ¶æ¯ä¸€æ­¥ã€‚åœ¨BraTSæµ‹è¯•é›†ä¸Šï¼Œæˆ‘ä»¬çš„æµç¨‹åœ¨å¤šä¸ªæŒ‘æˆ˜ä¸­å–å¾—äº†ä¸ŽæŽ’åé å‰ç®—æ³•ç›¸å½“çš„æ€§èƒ½ã€‚è¿™äº›å‘çŽ°è¯å®žï¼Œå®šåˆ¶çš„ç—…ç¶æ„ŸçŸ¥å¤„ç†å’Œæ¨¡åž‹é€‰æ‹©èƒ½å¤Ÿäº§ç”Ÿç¨³å¥çš„åˆ†å‰²ï¼ŒåŒæ—¶ä¸å°†æ–¹æ³•é”å®šäºŽç‰¹å®šçš„ç½‘ç»œæž¶æž„ã€‚æˆ‘ä»¬çš„æ–¹æ³•åœ¨ä¸´åºŠå®žè·µä¸­å…·æœ‰å®šé‡è‚¿ç˜¤æµ‹é‡çš„æ½œåŠ›ï¼Œæ”¯æŒè¯Šæ–­å’Œé¢„åŽã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

æ•´ä½“æ¡†æž¶æ˜¯ä¸€ä¸ªæ¨¡å—åŒ–ã€å¯é€‚åº”çš„åˆ†å‰²æµç¨‹ï¼ŒåŒ…æ‹¬æ¨¡åž‹é€‰æ‹©ã€è®­ç»ƒä¼˜åŒ–å’Œé¢„æµ‹åŽå¤„ç†ã€‚å…³é”®æŠ€æœ¯åˆ›æ–°ç‚¹åœ¨äºŽï¼š1ï¼‰åˆ©ç”¨å½±åƒç»„å­¦ç‰¹å¾è¿›è¡Œè‚¿ç˜¤äºšåž‹æ£€æµ‹ï¼Œä»¥å¹³è¡¡è®­ç»ƒæ•°æ®ï¼›2ï¼‰é‡‡ç”¨ç—…ç¶çº§æ€§èƒ½æŒ‡æ ‡æŒ‡å¯¼æ¨¡åž‹é›†æˆï¼Œç¡®å®šæ¯ä¸ªæ¨¡åž‹åœ¨é›†æˆä¸­çš„æƒé‡ï¼›3ï¼‰åº”ç”¨è‚¿ç˜¤å’Œç—…ç¶ç‰¹å¼‚æ€§åŽå¤„ç†è¿›ä¸€æ­¥ç»†åŒ–åˆ†å‰²ç»“æžœã€‚ä¸ŽçŽ°æœ‰æ–¹æ³•çš„ä¸»è¦åŒºåˆ«åœ¨äºŽï¼Œè¯¥æ–¹æ³•ä¸ä¾èµ–äºŽå•ä¸€ç½‘ç»œæž¶æž„ï¼Œè€Œæ˜¯é€šè¿‡çµæ´»ç»„åˆçŽ°æœ‰æ¨¡åž‹å’Œå®šåˆ¶å¤„ç†æ­¥éª¤ï¼Œå®žçŽ°é’ˆå¯¹ä¸åŒè‚¿ç˜¤ç±»åž‹çš„è‡ªé€‚åº”åˆ†å‰²ï¼Œæé«˜äº†æ³›åŒ–æ€§å’Œé²æ£’æ€§ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

åœ¨BraTS 2025 LighthouseæŒ‘æˆ˜èµ›çš„æµ‹è¯•é›†ä¸Šï¼Œè¯¥æµç¨‹åœ¨PEDã€MENã€MEN-RTå’ŒMETç­‰å¤šä¸ªæ•°æ®é›†ä¸Šå‡å–å¾—äº†ä¸ŽæŽ’åé å‰ç®—æ³•ç›¸å½“çš„åˆ†å‰²æ€§èƒ½ï¼Œè¯æ˜Žäº†å…¶åœ¨ä¸åŒè‚¿ç˜¤ç±»åž‹ä¸Šçš„ç¨³å¥æ€§å’Œæ³›åŒ–èƒ½åŠ›ï¼Œæ— éœ€é”å®šç‰¹å®šç½‘ç»œæž¶æž„å³å¯å®žçŽ°é«˜æ•ˆåˆ†å‰²ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶åœ¨ä¸´åºŠåŒ»å­¦å½±åƒåˆ†æžé¢†åŸŸå…·æœ‰é‡è¦åº”ç”¨ä»·å€¼ï¼Œå¯ç”¨äºŽè„‘è‚¿ç˜¤çš„å®šé‡æµ‹é‡ï¼Œæ”¯æŒè¯Šæ–­ã€é¢„åŽè¯„ä¼°å’Œæ²»ç–—è§„åˆ’ï¼Œç‰¹åˆ«æ˜¯åœ¨å¤šç±»åž‹è‚¿ç˜¤ï¼ˆå¦‚å„¿ç«¥è‚¿ç˜¤ã€è„‘è†œç˜¤ã€è½¬ç§»ç˜¤ï¼‰çš„MRIåˆ†å‰²ä»»åŠ¡ä¸­ï¼Œæœ‰åŠ©äºŽæå‡ä¸´åºŠå†³ç­–çš„å‡†ç¡®æ€§å’Œæ•ˆçŽ‡ã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Robust and generalizable segmentation of brain tumors on multi-parametric magnetic resonance imaging (MRI) remains difficult because tumor types differ widely. The BraTS 2025 Lighthouse Challenge benchmarks segmentation methods on diverse high-quality datasets of adult and pediatric tumors: multi-consortium international pediatric brain tumor segmentation (PED), preoperative meningioma tumor segmentation (MEN), meningioma radiotherapy segmentation (MEN-RT), and segmentation of pre- and post-treatment brain metastases (MET). We present a flexible, modular, and adaptable pipeline that improves segmentation performance by selecting and combining state-of-the-art models and applying tumor- and lesion-specific processing before and after training. Radiomic features extracted from MRI help detect tumor subtype, ensuring a more balanced training. Custom lesion-level performance metrics determine the influence of each model in the ensemble and optimize post-processing that further refines the predictions, enabling the workflow to tailor every step to each case. On the BraTS testing sets, our pipeline achieved performance comparable to top-ranked algorithms across multiple challenges. These findings confirm that custom lesion-aware processing and model selection yield robust segmentations yet without locking the method to a specific network architecture. Our method has the potential for quantitative tumor measurement in clinical practice, supporting diagnosis and prognosis.

